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HIV-1 infection and compartmentalization in diverse leukocyte targets significantly contribute to viral persistence during suppressive highly
active antiretroviral therapy (HAART). Longitudinal analyses were performed on envelope sequences of HIV-1 populations from plasma, CD4+
and CD8+ T lymphocytes in 14 patients receiving HAART and 1 therapy-naive individual. Phylogenetic reconstructions and analysis of molecular
variance revealed that HIV-1 populations in CD4+ and CD8+ T cells remained compartmentalized over time in most individuals. Analyses of viral
genetic variation demonstrated that, despite compartmentalization remaining over time, viral subpopulations tended not to persist and evolve but
instead broke down and became reconstituted by new founder viruses. Due to the profound impact of HAART on viral evolution, it was difficult to
discern whether these dynamics were ongoing during treatment or predominantly established prior to the commencement of therapy. The genetic
structure and viral founder effects observed in serially sampled T lymphocyte populations supported a scenario of metapopulation dynamics in the
tissue(s) where different leukocytes become infected, a factor likely to contribute to the highly variable way that drug resistance evolves in
different individuals during HAART.
© 2006 Elsevier Inc. All rights reserved.Keywords: HIV-1 population genetics; HAART; CD4+ T lymphocytes; CD8+ T lymphocytes; Metapopulation dynamicsIntroduction
Human immunodeficiency virus type 1 (HIV-1) selectively
infects and replicates in CD4+ T cells and tissue macrophages,
which accounts for many aspects of its pathogenesis. However,
the virus also targets other blood cells, and there is now
considerable evidence for productive HIV-1 infection in
monocytes (Crowe and Sonza, 2000; Innocenti et al., 1992;
Lambotte et al., 2000; McElrath et al., 1998; Patterson et al.,
1998, 1999; Sonza et al., 2001; Spear et al., 1990; Zhu et al.,
2002) and CD8+ T cells (Imlach et al., 2001; Kitchen et al.,⁎ Corresponding author.
E-mail address: nitin_saksena@wmi.usyd.edu.au (N.K. Saksena).
0042-6822/$ - see front matter © 2006 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.12.0311997, 1998; Livingstone et al., 1996; McBreen et al., 2001;
Saha et al., 2001a; Semenzato et al., 1998; Yang et al., 1998;
Zloza et al., 2003). As the suppression of viral replication in
CD4+ T cells becomes increasingly effective with current
antiretroviral regimens, the role of alternative cellular sites for
HIV-1 infection assumes a greater importance. Low-level HIV-1
replication in monocytes and natural killer (NK) cells has been
shown to contribute to the continued persistence and evolution
of the virus despite suppression of plasma viremia to below
detectable levels (Crowe and Sonza, 2000; Lambotte et al.,
2000; Sonza et al., 2001; Valentin et al., 2002; Zhu, 2000; Zhu
et al., 2002). Several studies have reported that CD8+ T cells
harbor substantial amounts of HIV-1 (Imlach et al., 2001;
Kitchen et al., 1997; Livingstone et al., 1996; McBreen et al.,
2001; Semenzato et al., 1995, 1998), although the overall
Table 1
Patient clinical data at each timepoint and length of time between sampling
Patient Timepoint Viral load
(copies/ml)
CD4+ T cells
(μl blood)
CD8+ T cells
(μl blood)
Time
between
sampling
1 i) b400 510 930 25 months
ii) 16,231 730 310
2 i) N100,000 270 1242 19 months
ii) b50 796 2380
3 i) 22,900 345 870 33 months
ii) 20,700 430 772
4 i) b400 200 1092 48 months
ii) 17,075 400 944
5 i) 603,495 70 910
ii) b400 400 1815 12 months
iii) b50 400 1815 24 months
6 i) 380,551 20 390
ii) 81,467 260 560 30 months
iii) 180,991 275 740 17 months
7 i) 84,000 450 870 36 months
ii) b400 630 720
8 i) 14,000 600 1030 39 months
ii) b400 790 990
9 i) 6118 480 1509
ii) b400 760 1330 12 months
iii) b50 962 1406 17 months
10 i) b400 470 1110 30 months
ii) 566 530 995
11 i) b400 75 765 33 months
ii) b400 185 905
12 i) b400 760 1683 19 months
ii) 39,513 600 2682
13 i) 116,198 170 1128 37 months
ii) b400 580 1740
14 i) b400 728 1792 31 months
ii) 11,100 645 1460
15 i) N100,000 144 1188 24 months
ii) b400 336 1008
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pathogenesis is yet to be clearly defined.
The treatment of HIV-1 with highly active antiretroviral
therapy (HAART) is further complicated by compartmentali-
zation of the virus in different tissues and cell types. This
provides an independent environment for viral evolution,
resulting in latent viral reservoirs (Chun et al., 1997a, 1997b;
Finzi et al., 1997; Wong et al., 1997) and providing a
mechanism for the development of antiretroviral drug resistance
(Eyre et al., 2000; Potter et al., 2003; Smit et al., 2004). Recent
analyses have provided evidence for genetic structure between
HIV-1 populations derived from different blood cell types
(Fulcher et al., 2004; Potter et al., 2003, 2004). However, the
extent to which HIV-1 populations in different leukocyte
compartments persist and evolve over time remains uncertain, a
factor that may be particularly relevant in the case of drug-
resistant HIV-1 strains. As individual HIV-1 subpopulations in
the blood turn over, it is important to establish whether they go
on to produce new viral lineages or break down over time to
become reconstituted by new founder strains. This process is
likely to differ in individual leukocyte compartments due to the
different lifetimes of pools of infected cells, and a lag in the
evolution of the virus in specific blood cell type(s) may
significantly influence the makeup of different HIV-1 sub-
populations in the blood.
To gain insights into these aspects of HIV-1 infection in
different leukocyte populations, we conducted a detailed
longitudinal analysis of viral envelope sequences derived
from plasma, CD4+ and CD8+ T cells of 14 patients receiving
HAART and 1 untreated individual. We provide evidence that
HIV-1 strains remain compartmentalized in CD4+ and CD8+ T
lymphocyte populations during the course of treatment with
HAART. Furthermore, strong evidence of viral founder effects
over multiple timepoints indicated that, rather than persisting
and evolving to form new viral lineages, CD4+ and CD8+ T cell
HIV-1 populations are subject to frequent re-colonization events
by new viral founders that subsequently turnover and establish
new viral populations.
Results
Cell type purification and sequence data
Between 2 and 3 timepoints samples were obtained from 15
HIV-1 seropositive individuals (Subtype B) (Table 1). All
patients (except therapy-naive Patient 6) received antiretroviral
treatment between the sampled timepoints. Samples from the
first timepoint were collected at baseline (prior to commencing
therapy) or immediately (within 1 week) following the
commencement of therapy. Follow-up timepoint(s) were
collected 12–48 months after the initial sampling. Although
treatment with HAART successfully repressed HIV-1 replica-
tion between the sampled timepoints, some individuals
experienced temporary spike(s) in plasma viral load during
this period. The purity of separated CD4+ and CD8+ T cell
fractions was assessed by fluorescent-activated cell sorting
(FACS) analysis. CD8+ T lymphocyte fractions contained verylow numbers of contaminating CD4+ cells (mean ± SD CD8+
cells: 99.64% ± 0.23) (Supplementary Fig. 1). Significant
evidence of genetic structure between HIV-1 populations
derived from CD4+ and CD8+ T lymphocyte fractions was
observed over multiple timepoints in most patients, further
confirming the purity of cell separations. HIV-1 proviral DNA
from CD4+ and CD8+ T cell fractions was amplified
successfully by nested PCR in all patients at each timepoint.
Reverse transcriptase-PCR (RT-PCR) of HIV-1 RNA from
plasma was successful in all cases where viral load was
detectable (N400 copies/ml). Five clones were sequenced from
each separated fraction (CD4+ Tcells, CD8+ Tcells and plasma)
(n = 395).
Phylogenetic reconstructions
Reconstruction of a tree generated from all 395 viral
sequences revealed that clones clustered in a patient-specific
manner, confirming the absence of PCR contamination (data not
shown). Individual ML trees were reconstructed for each patient
using HIV-1 sequences derived from plasma, CD4+ T cells and
CD8+ T cells over multiple timepoints. In most cases, CD4+ and
CD8+ T cell clones from the same timepoint clustered
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among CD4+ and CD8+ T cell HIV-1 populations. Although
there was a tendency to cluster according to population, CD4+
T-cell-derived viral clones were generally the most diverse
population. Sequences from CD4+ T cells showed the strongest
association with plasma-derived sequences in most patients.
CD8+ (and CD4+) T-cell-derived sequences from different
timepoints were not monophyletic in most cases, suggesting
subpopulation turnover and re-colonization by new founders
(Fig. 1).
Twelve of 15 patients had 2 timepoints sampled (Table 1).
Of these 12 individuals, 8 showed segregation of CD4+ and
CD8+-derived sequences at both timepoints (see Figs. 1b–d,
h, k, m–o), while 4 showed CD4+/CD8+ segregation at one
timepoint only. Three timepoints were obtained from 3
patients (Figs. 1e, f and i): of these 3 individuals, 2 showed
segregation of CD4+ and CD8+-derived sequences at all 3
timepoints (see Patients 6 and 9, Figs. 1f and i, respectively),
while the third showed population subdivision at 2 of 3
timepoints (Patient 5, Fig. 1e). Only 1 individual in the
patient group showed a random mixing of CD4+ and CD8+-
derived HIV clones at each timepoint, with little evidence of
cell type segregation (Patient 10, Fig. 1j).
Genetic diversity of HIV-1 subpopulations
In each patient, HIV-1 nucleotide diversity within a given
cell type was obtained by calculating the mean of pairwise
genetic distance comparisons within the population. The
average nucleotide diversity for each cell type HIV-1 population
over multiple timepoints was then calculated for each patient
(Fig. 2). In agreement with previous results (Potter et al., 2004),
HIV-1 diversity in CD8+ T cells was always lower than that of
CD4+ T cells, and this difference was statistically significant
over all patients (P b 0.01). Reflecting this, there was only a
poor correlation between average nucleotide diversity over
timepoints in CD4+ and CD8+ T cells over the patient group
(Pearson correlation coefficient r = 0.45). As nucleotide
diversity reflects the effective population size, these results
confirm that CD4+ T cells represent the main HIV-1 pool in
circulating T lymphocytes. The lower genetic diversity
exhibited by CD8+ T cell populations also indicated fewer
founder viruses in the tissues where these cells are infected.
Statistical analyses demonstrated that the diversity observed
among CD8+ T cell clones was still considerably higher than
that which could be attributed to possible Taq-Polymerase error.
This confirmed that HIV-1 sequences from CD8+ T cells did not
arise from re-sampling of identical starting templates (Supple-
mentary Table 1).
Analysis of molecular variance
The degree of genetic differentiation between HIV-1
sequences from CD4+ and CD8+ T cells was assessed in more
detail using AMOVA (Table 2). As there were 2 possible
sources of genetic structure (the cell types and the timepoints), 2
different hierarchical setups were investigated. In setup (a), celltypes constituted the groups and timepoints formed the
populations within each group. In setup (b), timepoints
constituted the groups and cell types formed the populations
within each group. Measurements of FCT revealed significant
evidence of genetic structure (Table 2). In the majority of cases,
hierarchical setup (b) was favored, with the fraction of variance
among timepoint groups significant at the 99% confidence level
in 9 of 15 patients. This supported the theory that CD4+ (or
CD8+) T-cell-derived viral populations sampled at later time-
point(s) arose from colonization and turnover of distinct
founder viruses (metapopulation model) (Frost et al., 2001a;
Potter et al., 2004). In 4 of 15 patients, hierarchical setup (a) was
valid, with the fraction of variance among cell type groups also
significant at the 99% confidence level (Table 2). Under setup
(a), a different CD4+ T cell HIV-1 population was observed at
the second sampling, however, it was more related to the
previously sampled CD4+ population than the corresponding
CD8+ T cell population (the same applied for CD8+ HIV-1
populations).
The fraction of variation among groups was not significant
for either hierarchical setup in only 2 cases (Patients 5 and 9).
Analysis of the fraction of variation between subpopulations
within groups (FSC) revealed significant values (99% confi-
dence level) for almost all patients (including Patients 5 and 9)
using both hierarchical setups (Table 2). The fraction of
variation among viral variants within a cell population (FST)
was significant at the 99% confidence level in all cases under
both setups, except for Patient 10 (significant at the 95%
confidence level) (Table 2).
Founder effects in CD4+ and CD8+ T cell HIV-1 populations
AMOVA calculations suggested that, in the majority of
patients, CD4+ and CD8+ HIV-1 populations at later timepoint
(s) arose from colonization by different founder viruses. These
features are compatible with metapopulation dynamics. As
previously demonstrated (Frost et al., 2001a; Potter et al., 2004),
founder effects in a viral population can be detected using the
Tajima's D statistic (Tajima, 1989). The higher the Tajima's D
statistic, the more founder effects can be expected which also
implies higher nucleotide diversity (Frost et al., 2001a).
Therefore, average nucleotide diversity and Tajima's D
statistics were calculated from pooled timepoint sequences of
individual leukocyte HIV-1 populations. This was performed
separately for CD4+ and CD8+ HIV-1 sequences in each patient.
Values were plotted, and the association between Tajima's D
and nucleotide diversity examined over the patient group (Fig.
3). A strong correlation existed between the Tajima's D statistic
and nucleotide diversity in each individual cell type population,
consistent with the action of founder effects (Fig. 3). The
Pearson correlation coefficient (r) in CD4+ and CD8+ T cell
populations was 0.8 and 0.82 respectively (P b 0.01). When
data from both cell type populations were combined together,
the correlation was marginally lower (r = 0.71) (P b 0.01).
These data further supported the theory that the genetic structure
observed in cell type and serial sampling arose from
colonization and localized turnover of new founder viruses.
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Fig. 1. Maximum likelihood trees showing phylogenetic relationships between HIV clones derived from CD4+ T cells, CD8+ T cells and plasma at different timepoints
in each patient. Bootstrap values were calculated using 1000 replicates and are indicated when≥70.● = plasma-derived HIV-1 clone,E = CD8+ T-cell-derived HIV-1
clone, □ = CD4+ T-cell-derived HIV-1 clone. Timepoints are specified by a number directly following each symbol.
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Fig. 2. Nucleotide diversity among CD4+ and CD8+ T cell HIV-1 populations in
different patients. The nucleotide diversity in each cell type population at a given
timepoint was calculated in a patient-specific manner by taking an average of all
pairwise genetic distance comparisons. Cell type values at each timepoint were
then combined to generate an average nucleotide diversity value for each cell
type in each patient.
Fig. 3. Estimates of Tajima's D against nucleotide diversity in CD4+ and CD8+
T-cell-derived HIV-1 populations. The correlation between Tajima's D and
nucleotide diversity in cell-type-specific HIV-1 populations over multiple
timepoints is indicated. = CD4+ T cells, ■ = CD8+ T cells. CD4+ T cell
Pearson correlation coefficient r = 0.78 (P b 0.01), CD8+ T cell Pearson
correlation coefficient r = 0.82 (P b 0.01), combined CD4+/CD8+ T cell Pearson
correlation coefficient r = 0.71 (P b 0.01).
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Results from the analyses above provide evidence that
sampling from different cellular compartments over time
revealed two sources of genetic structure, features consistent
with metapopulation dynamics. However, it was unclear
whether colonization by new founder viruses occurred between
the sampled timepoints (i.e. during HAART) or whether this
colonization was already established prior to the commence-
ment of therapy. The latter would be expected when therapy
resulted in efficient viral suppression with a slowing or
cessation of viral evolution. In this scenario, CD4+ and CD8+
HIV-1 subpopulations sampled at later timepoints were alreadyTable 2
Statistics from AMOVA
Patient FCT hierarchical setup FSC hierarch
(a) Cell type (b) Timepoint (a) Cell type
1 −0.10431 0.18233 a 0.57916 a
2 0.12614 a −0.06376 0.6768 a
3 −0.28149 0.39436 a 0.58274 a
4 0.19092 a −0.09514 0.71196 a
5 0.01034 0.12161 0.49078 a
6 −0.10914 0.23769 a 0.69304 a
7 −0.08571 0.15963 a 0.50734 a
8 0.08899 a 0.0066 0.37815 a
9 0.08091 −0.06371 0.54954 a
10 −0.13164 0.2407 a 0.25437 b
11 −0.13785 0.27163 a 0.69349 a
12 −0.06998 0.16749 a 0.5493 a
13 0.07311 a 0.00499 0.60232 a
14 −0.1187 0.24239 a 0.72074 a
15 −0.18722 0.27842 a 0.64172 a
AMOVAwas performed on CD4 and CD8 HIV-1 clones of each patient. Two hierar
within the groups, and (b) timepoints as groups and cell types as populations within
fraction of variation Vb / (Vb + Vc) among populations within a particular group. FST
population.
a Significant at the 99% confidence level.
b Significant at the 95% confidence level.established in the tissue(s) of infection prior to therapy and
subsequently released into the blood compartment between the
sampled timepoints. To examine these issues, an estimation of
phylogenies in units of genetic time rather than genetic distance
was more appropriate. Serially sampled or heterochronous
sequence data allow the estimation of evolutionary rates and
phylogenies in units of time (Rambaut, 2000). However, if viral
evolution was sufficiently suppressed by therapy, sequences at
later timepoints would not accumulate a significant number of
mutations. Therefore, we investigated the correlation of genetic
divergence and time between sampling using linear regression
analyses. Unfortunately, no consistent patterns were observed,
and the regression analyses were found to be prone to theical setup FST hierarchical setup
(b) Timepoint (a) Cell type (b) Timepoint
0.48411 a 0.53526 a 0.57818 a
0.71695 a 0.71756 a 0.6989 a
0.2538 a 0.46528 a 0.54807 a
0.76552 a 0.76695 a 0.74322 a
0.4379 a 0.49604 a 0.50626 a
0.59241 a 0.65954 a 0.68929 a
0.41412 a 0.46512 a 0.50765 a
0.41358 a 0.43349 a 0.41745 a
0.59264 a 0.58598 a 0.56668 a
0.02087 b 0.15622 b 0.25654 b
0.58366 a 0.65124 a 0.69675 a
0.46555 a 0.51776 a 0.55506 a
0.62093 a 0.6314 a 0.62282 a
0.63538 a 0.68759 a 0.72376 a
0.49663 a 0.57464 a 0.63678 a
chical setups were tested: (a) cell types as groups and timepoints as populations
the groups. FCT = the fraction of variation (Va/VT) among “groups”. FSC = the
= fraction of variation (Va + Vb) / VTamong viral variants within a particular cell
41S.J. Potter et al. / Virology 348 (2006) 35–46positioning of the root on the tree (data not shown). This was
particularly the case for patients that showed evidence for
hierarchical setup (b) from AMOVA. For these individuals,
placing the root on the branch that provided a good split
between timepoint groups sometimes resulted in a reasonable
correlation between divergence from the root and sampling
time. The potential artifact of rooting attributes most divergence
to evolution between sampling, while a scenario of no evolution
between timepoints may have been equally probable. For otherFig. 4. (a) Linear regression analysis of genetic divergence from root against sampling
Patient 6 HIV-1 timepoint sequences (CD4+, CD8+ and plasma compartments) optim
from timepoint 2 (plasma viremia below detection). Founder events (assuming CD4+
between each timepoint is shown on the lower bar.patients, there was a weak correlation between divergence and
sampling time, regardless of the position of the root.
In contrast to patients receiving HAART, Patient 6 (therapy
naive) showed clear evidence of evolution both prior to and
between timepoints. There was agreement between evolution-
ary rates predicted by both rooting methods for this patient (Fig.
4a), and the sequence data from this patient showed a good
correlation between divergence and sampling time (R2 = 0.81).
Clinical data from Patient 6 were supportive of these findings,time in therapy-naive Patient 6. (b) Maximum likelihood tree reconstructed from
ized under a tipdated model. HIV-1 sequences from plasma were not generated
T lymphocytes as the source) are shown at the indicated points. The time period
42 S.J. Potter et al. / Virology 348 (2006) 35–46showing persistently elevated plasma viral load over the time
period between sampling (data not shown). A maximum
likelihood analysis performed on sequences from Patient 6
revealed a rate of evolution of 0.006749 nucleotide substitu-
tions/site/year with confidence interval [0.003545, 0.009931].
The molecular clock for this patient was still rejected at the 95%
confidence interval, but not at the 99% confidence interval
(P = 0.036). An ML tree optimized under a tipdated clock
model was reconstructed from Patient 6 timepoint sequences
(Fig. 4b). This was informative on divergence and evolution
between timepoints. For example, at the second timepoint, there
was already significant divergence between the lineages that
were effectively sampled at that time and those to be sampled
from the next timepoint. However, the latter still evolved further
and diversified. Founder effects are plotted on the tree,
assuming that CD4+ T lymphocytes (as the predominant
reservoir of HIV in circulating leukocytes) are the source of
new founders in the CD8+ compartment (and not the reverse).
Discussion
As the suppression of HIV-1 replication in CD4+ T cells
becomes increasingly effective with current antiretroviral
regimens, the infection of other leukocyte populations assumes
greater significance. Despite the reduction of viral load in
plasma to below detectable levels, low level viral replication in
alternative cellular compartments such as monocytes and NK
cells contributes to viral persistence during HAART (Chun et
al., 1997a, 1997b; Crowe and Sonza, 2000; Finzi et al., 1997;
Lambotte et al., 2000; Sonza et al., 2001; Valentin et al., 2002;
Wong et al., 1997; Zhu, 2000; Zhu et al., 2002). CD8+ T cells
have been shown to harbor substantial amounts of HIV-1
(Imlach et al., 2001; Kitchen et al., 1997; Livingstone et al.,
1996; McBreen et al., 2001; Semenzato et al., 1995, 1998), and
the contribution of viral strains from this compartment to viral
pathogenesis over the course infection remains ill-defined.
Here, we conducted a detailed longitudinal analysis of HIV-1
envelope sequence variation in plasma, CD4+ and CD8+ T cell
populations of patients receiving HAART. We found strong
evidence of genetic subdivision in HIV-1 strains derived from
individual T cell populations over multiple timepoints. In
addition, it was evident that CD4+ and CD8+ T cell viral
populations were subject to frequent re-colonization events by
new viral founders that subsequently turned over establishing
new viral populations.
Previous studies conducted on HIV-1 subpopulations in
white spleen pulps (Cheynier et al., 1994; Frost et al., 2001a)
and diverse leukocytes (Potter et al., 2004) were suggestive of a
metapopulation model of HIV-1 replication. Under this model,
the total population of infected cells consists of a large number
of smaller subpopulations each of which is established by a
small number of founding cells that turn over at a high rate
(Frost et al., 2001a; Potter et al., 2004). Characterization of
HIV-1 envelope diversity revealed significant evidence of
genetic structure among viral subpopulations and indicated a
prominent role for founder effects in the establishment of
specific viral compartments. Although informative on HIV-1population dynamics at a given timepoint, it was still unclear
from these analyses whether individual viral subpopulations are
sustained over time and go on to produce distinct viral lineages
or whether they break down and become reconstituted by new
founders in line with the metapopulation model.
In this study, phylogenetic reconstructions and AMOVA
calculations revealed significant evidence for genetic structure
between CD4+ and CD8+ T-cell-derived HIV-1 populations in
almost all individuals (Fig. 1). Importantly, this genetic
structure was evident over multiple timepoints and was thus
consistent with the metapopulation model. In the majority of
cases, a hierarchical setup with timepoints groups (rather than
cell type groups) was favored, and therefore the genetic
structure observed was not compatible with sequences having
to adapt to a particular cell population (i.e. positive selection).
Furthermore, predictions of coreceptor utilization (Supplemen-
tary Table 2) and signature pattern analysis (VESPA) (data not
shown) provided no evidence that positive selection was
responsible for the compartmentalization observed. Variation
in the level of viral genetic structuring was also evident among
different patients (Table 2). This may arise because of relatively
small differences in the number of founders, with high levels of
population structure, and reduced diversity within subpopula-
tions. Founder effects are an important feature of the
metapopulation model (Frost et al., 2001a). A high rate of
subpopulation turnover distinguishes metapopulation dynamics
from other simple ‘island’ models of compartmentalization that
do not incorporate extinction. We found strong evidence of
founder effects in cell type HIV-1 populations over multiple
timepoints. There was a significant correlation between the
Tajima's D statistic and nucleotide diversity found over the
timepoints for each cell type (Fig. 3). Supporting this, HIV-1
clones from a given cell type at one timepoint were often
monophyletic, clustering independently from clones of the same
cell type at subsequent timepoint(s) (Fig. 1). Thus, for the
majority of patients, some of the cellular subpopulations at
different timepoints appeared to arise from different founder
viruses, and the genetic structure at later timepoints did not
appear to be merely the result of evolution from the previous
timepoint. In agreement with our previous study (Potter et al.,
2004), genetic diversity was always lower in CD8+ T cells than
CD4+ T cells (Fig. 2). Nucleotide diversity is a measure of
population size, so this observation confirms CD4+ T cells as
the main HIV-1 pool. Under the metapopulation scenario, it is
thus likely that CD4+ T cells replenish other less infected cell
populations (i.e. CD8+ T cells of later timepoints).
Studies examining the evolution of HIV-1 under the pressure
of potent HAART have attributed envelope gene divergence
between timepoint sampling to a build up of divergence prior to
therapy and/or residual replication in latently infected cells
(Frost et al., 2001b; Gunthard et al., 1999; Zhang et al., 1999).
Clinical data from our cohort showed that several individuals
experienced brief spike(s) in plasma viremia between sampling,
raising the possibility that viral evolution between timepoints
made some contribution to the genetic structure observed. Since
all but one patient received therapy between timepoints, it was
of interest to consider whether viral founder effects in source
43S.J. Potter et al. / Virology 348 (2006) 35–46tissues occurred during treatment with HAART, or, whether
they were established in source tissues prior to therapy to be
subsequently released into the blood compartment. Maximum
likelihood analysis represented one method of assessing the
contribution of evolutionary divergence, however, clock models
often give a poor fit to serially sampled HIV-1 sequences, and
therapy can have a profound impact on the continuity of viral
evolution (Drummond et al., 2001). Furthermore, as the ‘true’
root of each tree is unknown, the evolutionary direction was
unclear. With this in mind, we used a linear regression approach
to explore the correlation between genetic divergence and time.
This revealed that correlation patterns were particularly prone to
the method of rooting, making it difficult to discern between a
scenario of evolution between timepoints, divergence com-
pletely built up before therapy or a combination of both. Other
patients showed weak correlations independent of the root
which might indicate little or no evolution under therapy.
However, exact estimations of the contribution of viremic
spikes were difficult. Despite the possibility that new HIV-1
variants may have developed during spikes in plasma viremia,
the brief nature of these surges suggested that it was difficult for
new mutations to become fixed in the population. Sampling of
additional timepoints may help to resolve this issue. Interest-
ingly, therapy-naive Patient 6 showed the best correlation (Fig.
4a), allowing estimation of a phylogeny in time units (Fig. 4b).
This suggested that there was indeed a confounding effect of
therapy on viral evolution for the other patients.
The selected migration of HIV-infected cells to the specific
tissue(s) where individual leukocyte populations become
infected followed by localized turnover and expansion is likely
to be a mechanism by which viral compartmentalization arises
in different blood leukocyte populations (Poss et al., 1998;
Potter et al., 2004). There is considerable evidence that the
primary anatomical sites at which individual blood cell types
become infected may differ. While lymphoid tissue is the major
site of CD4+ T cell infection (Fox et al., 1991; Harper et al.,
1986; Pantaleo et al., 1991, 1993), CD8+ T cell infection is
likely to occur predominantly during the double-positive
(CD4+/CD8+) stage of thymic maturation (Kitchen et al.,
1997; McBreen et al., 2001; Lee et al., 1997; Brooks et al.,
2001). Circulating activated CD8+ T cells which transiently
express the CD4 receptor are also likely to contribute to the total
infected CD8+ T cell viral pool (Imlach et al., 2001; Flamand et
al., 1998; Kitchen et al., 2002). Whether HIV-1 infection of
CD8+ T cells can also occur by a CD8-dependent manner is still
a topic of debate, despite reports demonstrating this mechanism
(Saha et al., 2001a, 2001b). In our study, a considerable degree
of divergence in CD8+ T cell HIV-1 populations was notable in
some patients (e.g. Patient 10), and CD8+-derived clones from
different timepoints clustered separately in most individuals.
This suggests that a range of different viral founders may
establish infection in the CD8+ T cell compartment.
Recent studies demonstrating HIV-1 subpopulation structure
and founder effects in specific viral compartments were
consistent with a metapopulation model of HIV-1 replication
(Frost et al., 2001a, 2001b; Potter et al., 2004). However, the
extent to which individual HIV-1 subpopulations persist andevolve producing new viral lineages was unknown. Here, we
demonstrate that HIV-1 populations in CD4+ and CD8+ T cells
remain compartmentalized over time, a factor that can be
attributed to frequent colonization events by new founder
viruses followed by the rapid turnover of these populations (in
agreement with the metapopulation model). The successful
suppression of HIV-1 replication in CD4+ T cells during
HAART increases the significance of other leukocyte popula-
tions targeted by the virus. Localized turnover of cell-type-
specific HIV-1 populations is likely to influence the highly
variable way in which drug resistance evolves in different
individuals, and further characterization of the dynamics and
persistence of HIV-1 replication in diverse leukocyte popula-
tions should assist in the design and implementation of more
effective antiretroviral strategies.
Methods
Patient clinical data
Between 2 and 3 timepoint samples from 15 HIV-1
seropositive (Subtype B) individuals were obtained after
informed consent. Clinical data from sampled timepoints are
shown in Table 1. Samples from the first timepoint were
collected at baseline (prior to commencing therapy) or
immediately (within 1 week) following the commencement of
therapy (Table 1). Follow-up timepoint(s) were collected 12–48
months after the initial sampling. With the exception of Patient
6 who remained antiretroviral therapy-naive, all patients
received antiretroviral treatment between the sampled time-
points. In general, HAART treatment was successful in the
suppression of plasma viremia, although some individuals
experienced one or more temporary spike(s) in plasma viral load
between sampling.
Cell type purification and sequence data
Quantification of HIV-1 RNA from plasma samples was
performed in real time using an Amplicor HIV-1 Monitor Test
Version 1.0 kit (Roche Diagnostics, Sydney, Australia).
Peripheral blood mononuclear cell (PBMC) samples from
different timepoints were thawed and allowed to recover briefly
in media before washing twice in PBS/EDTA (2mM). CD4+ and
CD8+ T cells were purified by positive isolation with antibody-
conjugated magnetic beads (Dynal Biotech, Oslo, Norway). The
purity of separated CD4+ and CD8+ Tcell fractions was assessed
by fluorescent-activated cell sorting (FACS) analysis. Polymer-
ase chain reactions (PCR), cloning and sequencing experiments
were performed as previously described (Potter et al., 2004). A
nested PCR was used to amplify a 600 bp fragment (C2–V5) of
the envelope gene. The external primer pair used was either 5′-
ATGGGATCAAAGCCTAAAGCCATGTG-3′ (fwd) and 5′-
GTGCTTCCTGCTGCTCCCAAGAACCCAAG-3′ (rev), or
5′-CCATGTGTAAAATTAACCCCA-3′ (fwd) and 5′-ATTC-
CAAGGCACAGCAGACA-3′ (rev). Internal round primer
sequences were 5′-CTGTTAAATGGCAGTCTAGCAGAA-
GAA-3′ (fwd) and 5′-CACTTCTCCAATTGTCCCTCA-3′
44 S.J. Potter et al. / Virology 348 (2006) 35–46(rev). Thermocycling conditions for both external and internal
round PCRs were as follows: one cycle of 95 °C for 15 min then
35 cycles of 94 °C for 30 s/57 °C for 30 s/72 °C for 45 s and a
final a single cycle of 72 °C for 7 min. Independent PCR
experiments were performed in triplicate on each separated
fraction, and pooled products were used to generate compart-
ment-specific clones. Five clones were sequenced from each
separated fraction (CD4+ T cells, CD8+ T cells and plasma) at
each timepoint (n = 395). PCR experiments to determine the
Taq-Polymerase error rate were conducted in parallel (Supple-
mentary Table 2).
Sequence analyses
Phylogenetic reconstructions
All sequences were aligned using clustalw (Thompson et al.,
1994) with default parameters and manually edited. Phyloge-
netic trees were reconstructed using a maximum likelihood
(ML) heuristic search algorithm under the general time
reversible (GTR) model with gamma distributed rate heteroge-
neity among sites in PAUP*v4.0b2 (Swofford, 1999). Bootstrap
values were calculated using 1000 replicates.
Genetic diversity
The genetic diversity was calculated in ARLEQUIN
(Schneider et al., 2000) using pairwise distances as estimated
under the Kimura two-parameter model (Kimura, 1980) with
gamma distributed rate variability among sites. The nucleotide
diversity is given by p ¼Pki ¼ 1
P
j b 1 pipjdˆij, where dˆij is the
estimate of the number of substitutions having occurred since
the divergence of haplotypes i and j, k is the number of
haplotypes and pi is the frequency of haplotype i.
Analysis of molecular variance
The genetic structure between HIV-1 populations from CD4+
and CD8+ T cells over timepoints was quantified using
estimates of FST, the fraction of total genetic variation between
subpopulations (Wright, 1951). FST estimates were calculated
using an analysis of molecular variance (AMOVA) (Excoffier et
al., 1992) in ARLEQUIN ver.2000. The significance for
rejecting the null hypothesis of a random distribution of genetic
variation was determined using 10,000 randomizations of
sequences between populations.
Serial sampling of CD4+ and CD8+ T lymphocytes can result
in 2 possible sources of genetic structure: the cell types and the
timepoints. Therefore, 2 different hierarchical setups were
employed to test which was the more significant source of
structure. In setup (a), cell types constituted the groups and
timepoints formed the populations within each group. In setup
(b), timepoints constituted the groups and cell types formed the
populations within each group.
There were 3 variance components in the analysis:
Va = variance “among groups”, Vb = variance “among
populations within groups”, Vc = variance “within popula-
tions” (VT = total variance). The fraction of variation between
the 2 groups was defined as FCT = (Va/VT). In setup (a), thisrepresented the fraction of variation between the CD4+ and
CD8+ T cell groups, and in setup (b), the fraction of variation
between timepoints 1 and 2. The fraction of variation between
subpopulations within groups was defined as FSC = Vb/
(Vb + Vc). In setup (a), this was the fraction of variation among
the timepoint 1 and 2 populations within the CD4+ group and
the fraction of variation between timepoints 1 and 2 within the
CD8+ group. In setup (b), FSC represented the fraction of
variation between CD4+ and CD8+ populations within the
timepoint 1 group and the fraction of variation between CD4+
and CD8+ populations within the timepoint 2 group. The third
fixation index was the fraction of variation among viral variants
within a cell population FST = (Va/Va + Vb). In setup (a), this
tested for structure within timepoints 1 and 2 of the CD4+
group and within timepoints 1 and 2 of the CD8+ group. In
setup (b), FST tested for structure within the CD4
+ and CD8+
populations of timepoint 1 and the CD4+ and CD8+ popu-
lations of timepoint 2.
Founder effects
Founder effects in cell-type-specific HIV-1 populations were
assessed using the Tajima's D statistic, a comparison of pairwise
diversity with the number of variable sites in a sample of
sequences (Tajima, 1989). Tajima's D statistics were calculated
in ARLEQUIN ver.2000. Nucleotide diversity and Tajima's D
statistics derived from pooled CD4+ and pooled CD8+ HIV-1
populations in each patient were examined for a correlation over
the whole patient group.
Molecular clock analysis
Exploratory linear regression analysis was performed
using the program Path-O-Gen (kindly provided by A.
Rambaut). This program allows plotting of root-to-tip
divergence based on maximum likelihood estimates against
sampling time. Molecular clock analysis was performed
using the program Rhino (available at http://evolve.zoo.ox.ac.
uk). This program provides a maximum likelihood estimate
of the evolutionary rate assuming a constant rate of
substitution (molecular clock) while accommodating the
dates of isolation. Confidence intervals for these parameters
were estimated using the likelihood ratio test (LRT) principle
(Rambaut, 2000). The molecular clock was tested using the
LRT.
Additional sequence analyses
Searches for cell-type-specific amino acid changes were
performed using viral epidemiology signature pattern analysis
(VESPA) (Korber and Myers, 1992). Predictions of coreceptor
use were made using software available at (http:/bik.microbiol.
washington.edu/computing/pssm) (Jensen et al., 2003).
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